Inventiva S.A. (IVA) stock
IVANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as IVEVF
$3.22−0.10 (-3.01%)
Close on Nov 17, 2026Market cap $622.22MP/E –Yield –
Inventiva total assets
Total assets on the balance sheet at the end of each period.
Inventiva's total assets was €251.21M at Jun 30, 2026. For fiscal 2025 it was €249.51M, up 109.7% from the year before. The highest annual figure on record is €249.51M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €249.51M | +109.7% |
| FY2024 | Dec 31, 2024 | €118.97M | +71.0% |
| FY2023 | Dec 31, 2023 | €69.56M | -40.0% |
| FY2022 | Dec 31, 2022 | €116.00M | -4.9% |
| FY2021 | Dec 31, 2021 | €121.99M | -12.2% |
| FY2020 | Dec 31, 2020 | €138.92M | +143.9% |
| FY2019 | Dec 31, 2019 | €56.96M | -28.6% |
| FY2018 | Dec 31, 2018 | €79.81M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | €251.21M | +537.2% |
| Q4 FY2025 | Dec 31, 2025 | €249.51M | +258.7% |
| Q2 FY2025 | Jun 30, 2025 | €178.96M | +152.7% |
| Q4 FY2024 | Dec 31, 2024 | €118.97M | +2.6% |
| Q2 FY2024 | Jun 30, 2024 | €39.43M | -67.7% |
| Q4 FY2023 | Dec 31, 2023 | €69.56M | -49.9% |
| Q2 FY2023 | Jun 30, 2023 | €70.82M | +24.3% |
| Q4 FY2022 | Dec 31, 2022 | €116.00M | +45.3% |
| Q4 FY2021 | Dec 31, 2021 | €121.99M | – |
| Q4 FY2020 | Dec 31, 2020 | €138.92M | – |
| Q4 FY2019 | Dec 31, 2019 | €56.96M | – |
| Q4 FY2018 | Dec 31, 2018 | €79.81M | – |
See a number that looks wrong?